Molecular staging for survival prediction of colorectal cancer patients

Journal of Clinical Oncology

Volumn 23, Issue 15, 2005, Pages 3526-3535

  Eschrich, Steven ^a   Yang, Ivana ^a   Bloom, Greg ^a   Kwong, Ka Yin ^a   Boulware, David ^a   Cantor, Alan ^a   Coppola, Domenico ^a   Kruhøffer, Mogens ^a   Aaltonen, Lauri ^a   Orntoft, Torben F ^a   Quackenbush, John ^a   Yeatman, Timothy J ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEU DIFFERENTIATION FACTOR; OSTEOPONTIN; COMPLEMENTARY DNA; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CANCER CLASSIFICATION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DNA FINGERPRINTING; DNA MICROARRAY; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; UNINDEXED SEQUENCE; ADULT; COHORT ANALYSIS; COLORECTAL TUMOR; COMPARATIVE STUDY; FEMALE; GENETICS; HISTORY; MALE; METHODOLOGY; MIDDLE AGED; MOLECULAR BIOLOGY; MORTALITY; MULTIMODALITY CANCER THERAPY; NONPARAMETRIC TEST; PATHOLOGY; PREDICTION AND FORECASTING; PROBABILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL; TUMOR SUPPRESSOR GENE;

ADULT; COHORT STUDIES; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DNA FINGERPRINTING; DNA, COMPLEMENTARY; FEMALE; GENES, DCC; HISTORY, 18TH CENTURY; HUMANS; MALE; MIDDLE AGED; MOLECULAR BIOLOGY; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 20644443287     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.00.695     Document Type: Article

References (20)

1. Dukes C: The classification of cancer in the rectum. J Pathol Bacteriol 35:323, 1932
2. Ramaswamy S, Tamayo P, Rifkin R, et al: Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci U S A 98:15149-15154, 2001
3. Bloom G, Yang IV, Boulware D, et al: Multiplatform, multi-site microarray based human tumor classification. Am J Pathol 164:9-16, 2004
4. Bhattacharjee A, Richards WG, Staunton J, et al: Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A 98:13790-13795, 2001
5. Khan J, Wei JS, Ringner M, et al: Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med 7:673-679, 2001
6. Sorlie T, Tibshirani R, Parker J, et al: Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 100:8418-8423, 2003
7. Agrawal D, Chen T, Irby R, et al: Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 94:513-521, 2002
8. Sanchez-Carbayo M, Socci ND, Lozano JJ, et al: Gene discovery in bladder cancer progression using cDNA microarrays. Am J Pathol 163: 505-516, 2003
9. Shipp MA, Ross KN, Tamayo P, et al: Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 8:68-74, 2002
10. van 't Veer LJ, Dai H, van de Vijver MJ, et al: Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530-536, 2002
11. van de Vijver MJ, He YD, van't Veer LJ, et al: A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999-2009, 2002
12. Ramaswamy S, Ross KN, Lander ES, et al: A molecular signature of metastasis in primary solid tumors. Nat Genet 33:49-54, 2003
13. Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98:5116-5121, 2001
14. de Hoon MJ, Imoto S, Nolan J, et al: Open source clustering software. Bioinformatics 20: 1453-1454, 2004
15. Dyrskjot L, Thykjaer T, Kruhoffer M, et al: Identifying distinct classes of bladder carcinoma using microarrays. Nat Genet 33:90-96, 2003
16. Fahlman SE: Faster-Learning Variations on Back-Propagation: An Empirical Study, Proceedings of the 1988 Connectionist Models Summer School. Los Altos, CA, Morgan-Kaufmann, 1988
17. Fedarko NS, Jain A, Karadag A, et al: Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Res 7:4060-4066, 2001
18. Yeatman TJ, Chambers AF: Osteopontin and colon cancer progression. Clin Exp Metastasis 20:85-90, 2003
19. Carraway KL III, Weber JL, Unger MJ, et al: Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases. Nature 387:512-516, 1997
20. Wang Y, Jatkoe T, Zhang Y, et al: Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. J Clin Oncol 22:1564-1571, 2004